ImmuCell Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 225,595 | $1.16 M | 0.00% | 2.76% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 136,989 | $705,493 | -8.36% | 1.68% |
CRESSET ASSET MANAGEMENT, LLC | 02/14/2025 | 132,001 | $679,806 | -50.00% | 1.62% |
02/14/2025 | 131,195 | $675,654 | 100.00% | 1.61% | |
BLEICHROEDER LP | 02/14/2025 | 101,594 | $523,209 | 0.00% | 1.24% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 66,306 | $341,475 | -8.77% | 0.81% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 64,538 | $332,462 | 13.90% | 0.79% |
SHUFRO ROSE & CO LLC | 02/25/2025 | 61,028 | $314,295 | -2.21% | 0.75% |
STRATEGIC FINANCIAL SERVICES, INC, | 02/11/2025 | 31,000 | $159,650 | 0.00% | 0.38% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 02/07/2025 | 24,356 | $125,434 | 100.00% | 0.30% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 21,354 | $109,973 | 0.00% | 0.26% |
PROSPERITY PLANNING, INC. | 01/17/2025 | 16,000 | $82,400 | 0.00% | 0.20% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 14,403 | $74,175 | 0.64% | 0.18% |
UBS GROUP AG | 02/14/2025 | 12,580 | $64,787 | -21.09% | 0.15% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 11,604 | $59,761 | 100.00% | 0.14% |
ESSEX FINANCIAL SERVICES, INC. | 01/29/2025 | 11,000 | $56,650 | 0.00% | 0.13% |
HM PAYSON & CO | 02/07/2025 | 4,000 | $20,600 | 0.00% | 0.05% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 806 | $4,151 | -27.78% | 0.01% |
CAPITAL ADVISORS, LTD. LLC | 02/04/2025 | 100 | $1,000 | 100.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 19 | $98 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 11 | $57 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 1 | $4 | 0.00% | 0.00% |
ImmuCell Corporation institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of ImmuCell Corporation. The most heavily invested institutionals were:
VANGUARD GROUP INC: 225,595
RENAISSANCE TECHNOLOGIES LLC: 136,989
Cresset Asset Management, LLC: 132,001
Bleichroeder LP: 101,594
DIMENSIONAL FUND ADVISORS LP: 66,306
GEODE CAPITAL MANAGEMENT, LLC: 64,538
14.76% of ImmuCell Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 1.13 M shares in the last 24 months. This purchase volume represents approximately $6.22 M in transactions.